The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Olanzapine Versus Aprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting: A Randomized Phase III Trial
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The National Comprehensive Cancer Network: Present and future directions
McGivney, W. T. (1998) · Cancer · doi:10.1002/(sici)1097-0142(19980515)82:10+<2057::aid-cncr14>3.0.co;2-a · Cited by 16,766
Assessing symptom distress in cancer patients: The M. D. Anderson Symptom Inventory
Cleeland, C. S., Mendoza, T. R., Wang, X. S., Chou, C., Harle, M. T., Morrissey, M., & Engstrom, M. C. (2000) · Cancer · doi:10.1002/1097-0142(20001001)89:7<1634::aid-cncr29>3.0.co;2-v · Cited by 1,360
Radioreceptor Binding Profile of the Atypical Antipsychotic Olanzapine
Bymaster, F. P., Calligaro, D. O., Falcone, J. F., Marsh, R. D., Moore, N. A., Tye, N. C., Seeman, P., & Wong, D. T. (1996) · Neuropsychopharmacology · doi:10.1016/0893-133x(94)00129-n · Cited by 1,062
Hesketh, P. J., Grunberg, S. M., Gralla, R. J., Warr, D. G., Roila, F., de Wit, R., Chawla, S. P., Carides, A. D., Ianus, J., Elmer, M. E., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.01.095 · Cited by 779
American Society of Clinical Oncology Guideline for Antiemetics in Oncology: Update 2006
Kris, M. G., Hesketh, P. J., Somerfield, M. R., Feyer, P., Clark-Snow, R., Koeller, J. M., Morrow, G. R., Chinnery, L. W., Chesney, M. J., Gralla, R. J., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.06.9591 · Cited by 740
Roila, F., Herrstedt, J., Aapro, M., Gralla, R. J., Einhorn, L. H., Ballatori, E., Bria, E., Clark-Snow, R. A., Espersen, B. T., Feyer, P., et al. (2010) · Annals of Oncology · doi:10.1093/annonc/mdq194 · Cited by 680
Antipsychotic-induced weight gain: a review of the literature.
Allison, D. B., & Casey, D. E. (2001) · PubMed · Cited by 595
Poli‐Bigelli, S., Rodrigues‐Pereira, J., Carides, A. D., Julie Ma, G., Eldridge, K., Hipple, A., Evans, J. K., Horgan, K. J., Lawson, F., & On behalf of the Aprepitant Protocol 054 Study Group (2003) · Cancer · doi:10.1002/cncr.11433 · Cited by 564
Bloechl-Daum, B., Deuson, R. R., Mavros, P., Hansen, M., & Herrstedt, J. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.05.6382 · Cited by 497
Gralla, R., Lichinitser, M., Van der Vegt, S., Sleeboom, H., Mezger, J., Peschel, C., Tonini, G., Labianca, R., Macciocchi, A., & Aapro, M. (2003) · Annals of Oncology · doi:10.1093/annonc/mdg417 · Cited by 467
Warr, D. G., Hesketh, P. J., Gralla, R. J., Muss, H. B., Herrstedt, J., Eisenberg, P. D., Raftopoulos, H., Grunberg, S. M., Gabriel, M., Rodgers, A., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.09.050 · Cited by 463
Eisenberg, P., Figueroa‐Vadillo, J., Zamora, R., Charu, V., Hajdenberg, J., Cartmell, A., Macciocchi, A., & Grunberg, S. (2003) · Cancer · doi:10.1002/cncr.11817 · Cited by 400
Reduction of Cisplatin-Induced Emesis by a Selective Neurokinin-1–Receptor Antagonist
Navari, R. M., Reinhardt, R. R., Gralla, R. J., Kris, M. G., Hesketh, P. J., Khojasteh, A., Kindler, H., Grote, T. H., Pendergrass, K., Grunberg, S. M., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901213400304 · Cited by 370
Self-citationAapro, M. S., Grunberg, S. M., Manikhas, G. M., Olivares, G., Suarez, T., Tjulandin, S. A., Bertoli, L. F., Yunus, F., Morrica, B., Lordick, F., et al. (2006) · Annals of Oncology · doi:10.1093/annonc/mdl137 · Cited by 338
Vardy, J., Chiew, K. S., Galica, J., Pond, G. R., & Tannock, I. F. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603048 · Cited by 262
Schmoll, H. J., Aapro, M. S., Poli-Bigelli, S., Kim, H.-K., Park, K., Jordan, K., von Pawel, J., Giezek, H., Ahmed, T., & Chan, C. Y. (2006) · Annals of Oncology · doi:10.1093/annonc/mdl019 · Cited by 232
Rapoport, B. L., Jordan, K., Boice, J. A., Taylor, A., Brown, C., Hardwick, J. S., Carides, A., Webb, T., & Schmoll, H.-J. (2010) · Supportive Care in Cancer · doi:10.1007/s00520-009-0680-9 · Cited by 229
New-Onset Diabetes Mellitus and Diabetic Ketoacidosis Associated With Olanzapine Treatment
Goldstein, L. E., Sporn, J., Brown, S., Kim, H., Finkelstein, J., Gaffey, G. K., Sachs, G., & Stern, T. A. (1999) · Psychosomatics · doi:10.1016/s0033-3182(99)71210-7 · Cited by 220
Clinical research of Olanzapine for prevention of chemotherapy-induced nausea and vomiting
Tan, L., Liu, J., Liu, X., Chen, J., Yan, Z., Yang, H., & Zhang, D. (2009) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/1756-9966-28-131 · Cited by 201
Rojas, C., Thomas, A. G., Alt, J., Stathis, M., Zhang, J., Rubenstein, E. B., Sebastiani, S., Cantoreggi, S., & Slusher, B. S. (2010) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2009.10.002 · Cited by 199
The Italian Group for Antiemetic Research (2000) · New England Journal of Medicine · doi:10.1056/nejm200005253422102 · Cited by 192
Navari, R. M., Einhorn, L. H., Loehrer, P. J., Passik, S. D., Vinson, J., McClean, J., Chowhan, N. M., Hanna, N. H., & Johnson, C. S. (2007) · Supportive Care in Cancer · doi:10.1007/s00520-007-0248-5 · Cited by 151
Self-citationNavari, R. M., Einhorn, L. H., Passik, S. D., Loehrer, P. J., Johnson, C. S., Mayer, M. L., McClean, J., Vinson, J., & Pletcher, W. (2005) · Supportive Care in Cancer · doi:10.1007/s00520-004-0755-6 · Cited by 147
Self-citationWhole brain radiotherapy with radiosensitizer for brain metastases
Viani, G. A., Manta, G. B., Fonseca, E. C., Fendi, L. I. D., Afonso, S., & Stefano, E. J. (2009) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/1756-9966-28-1 · Cited by 136
Potent antagonism of 5-HT3 and 5-HT6 receptors by olanzapine
Bymaster, F. P., Falcone, J. F., Bauzon, D., Kennedy, J. S., Schenck, K. W., DeLapp, N. W., & Cohen, M. L. (2001) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)01399-1 · Cited by 122
Reduced Ghrelin Secretion in the Hypothalamus of Rats due to Cisplatin-Induced Anorexia
Yakabi, K., Sadakane, C., Noguchi, M., Ohno, S., Ro, S., Chinen, K., Aoyama, T., Sakurada, T., Takabayashi, H., & Hattori, T. (2010) · Endocrinology · doi:10.1210/en.2010-0061 · Cited by 110
Hesketh, P. J., Grunberg, S. M., Herrstedt, J., de Wit, R., Gralla, R. J., Carides, A. D., Taylor, A., Evans, J. K., & Horgan, K. J. (2006) · Supportive Care in Cancer · doi:10.1007/s00520-005-0914-4 · Cited by 98
Pharmacological Management of Chemotherapy-Induced Nausea and Vomiting: Focus on Recent Developments
Navari, R. M. (2009) · Drugs · doi:10.2165/00003495-200969050-00002 · Cited by 91
Self-citationPathogenesis-based treatment of chemotherapy-induced nausea and vomiting--two new agents.
Navari, R. M. (2003) · PubMed · Cited by 89
Self-citationGrote, T., Hajdenberg, J. J., Cartmell, A., Ferguson, S., Ginkel, A., & Charu, V. (2006) · PubMed · Cited by 89
Anti-emetic activity of ghrelin in ferrets exposed to the cytotoxic anti-cancer agent cisplatin
Rudd, J. A., Ngan, M. P., Wai, M. K., King, A. G., Witherington, J. J., Andrews, P. L. R., & Sanger, G. J. (2005) · Neuroscience Letters · doi:10.1016/j.neulet.2005.08.062 · Cited by 84
A pilot study of Interpersonal Psychotherapy by telephone with cancer patients and their partners
Donnelly, J. M., Kornblith, A. B., Fleishman, S., Zuckerman, E., Raptis, G., Hudis, C. A., Hamilton, N., Payne, D., Massie, M. J., Norton, L., et al. (2000) · Psycho-Oncology · doi:10.1002/(sici)1099-1611(200001/02)9:1 · Cited by 65
Passik, S. D., Kirsh, K. L., Theobald, D. E., Dickerson, P., Trowbridge, R., Gray, D., Beaver, M., Comparet, J., & Brown, J. (2003) · Journal of Pain and Symptom Management · doi:10.1016/s0885-3924(03)00078-2 · Cited by 56
A phase II trial of olanzapine for the prevention of chemotherapy induced nausea and vomiting (CINV)
Navari, R. M., Einhorn, L. H., Loehrer, P. J., Passik, S. D., Vinson, J., Mayer, M. L., Pletcher, W., & McClean, J. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.22.14_suppl.8046 · Cited by 16
Self-citation
Cited by
Roila, F., Molassiotis, A., Herrstedt, J., Aapro, M., Gralla, R. J., Bruera, E., Clark-Snow, R. A., Dupuis, L. L., Einhorn, L. H., Feyer, P., et al. (2016) · Annals of Oncology · doi:10.1093/annonc/mdw270 · Cited by 574
Antiemetic Prophylaxis for Chemotherapy-Induced Nausea and Vomiting
Navari, R. M., & Aapro, M. (2016) · New England Journal of Medicine · doi:10.1056/nejmra1515442 · Cited by 477
Self-citationOlanzapine for the prevention of chemotherapy-induced nausea and vomiting.
Navari, R. M., Qin, R., Ruddy, K. J., Liu, H., Powell, S. F., Bajaj, M., Dietrich, L., Biggs, D., Lafky, J. M., & Loprinzi, C. L. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1515725 · Cited by 452
Self-citation
Metadata
- Authors
- Navari, R. M., Gray, S. E., & Kerr, A. C.
- Venue
- The Journal of Supportive Oncology
- Publisher
- Elsevier BV
- Published
- 2011-09
- Volume
- 9
- Issue
- 5
- Pages
- 188-195
- ISSN
- 1544-6794 (ISSN-L)
- OpenAlex
- W2055125378
- Cited by
- 319
- References
- 34
- FWCI
- 15.37
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.